Latest MS News


Clinical Trials

A list of multiple sclerosis clinical trials provided by the U.S. National Institutes of Health.

Recent Comments


Topics

« Biogen Idec Results | Main | Acorda Drug Results »

The Drought is Over

Man, there has been a shortage in news about multiple sclerosis lately. This week there's been more.

There was news that genetic variations have been identified as a possible reason for the interferon drugs behaving so differently for different people. I've touched on this before. I think this will lead to a more customized approach to MS treatments. It could even be that MS is actually a superset of diseases that we conveniently combine into one simply because we don't understand it well enough. The response to the drugs varies so greatly in individuals - we need to find the explanation and this genetic research is a step in that direction.

Then, I read a quote that Montel Williams claims if 'he can do it, anyone can.' I think he was referring to his pain management regimen. Once again, give me a break. How can he pretend for one minute to know how anyone else feels or will respond to treatments? MS affects everyone differently, so if he can do it, that's great news for him only. In all fairness, he has raised a lot of money and awareness for the cause. I just get the sense it's self-serving at times.

I'm glad the MS news drought is over - looking forward to more.


Hosting by Yahoo!

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)